BR0315139A - Agentes antibacterianos de tetraidroquinolina tricìclica - Google Patents
Agentes antibacterianos de tetraidroquinolina tricìclicaInfo
- Publication number
- BR0315139A BR0315139A BR0315139-5A BR0315139A BR0315139A BR 0315139 A BR0315139 A BR 0315139A BR 0315139 A BR0315139 A BR 0315139A BR 0315139 A BR0315139 A BR 0315139A
- Authority
- BR
- Brazil
- Prior art keywords
- antibacterial agents
- tetrahydroquinoline
- tricyclically
- tetrahydroquinoline antibacterial
- human
- Prior art date
Links
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 title abstract 6
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41668502P | 2002-10-07 | 2002-10-07 | |
| US42718902P | 2002-11-18 | 2002-11-18 | |
| US45762203P | 2003-03-26 | 2003-03-26 | |
| PCT/IB2003/004389 WO2004031195A1 (en) | 2002-10-07 | 2003-10-03 | Tricyclic tetrahydroquinoline antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0315139A true BR0315139A (pt) | 2005-08-09 |
Family
ID=32074379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0315139-5A BR0315139A (pt) | 2002-10-07 | 2003-10-03 | Agentes antibacterianos de tetraidroquinolina tricìclica |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US7208490B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1551849B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4009652B2 (cg-RX-API-DMAC7.html) |
| AR (1) | AR041546A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE473985T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003264768A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0315139A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2500824C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1110821T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60333379D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1551849T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05002701A (cg-RX-API-DMAC7.html) |
| PT (1) | PT1551849E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1551849T1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI295671B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004031195A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| CA2606847A1 (en) * | 2005-05-09 | 2006-11-16 | Warner-Lambert Company Llc | Antibacterial agents |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
| RU2010103101A (ru) * | 2007-07-02 | 2011-08-10 | Астразенека Аб (Se) | Химические соединения |
| US20110178064A1 (en) | 2007-07-16 | 2011-07-21 | Astrazeneca R&D | Spiro condensed barbituric acid derivatives for use as antibacterial |
| TW201020258A (en) * | 2008-10-14 | 2010-06-01 | Astrazeneca Ab | Chemical compounds 542 |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| RU2505539C2 (ru) * | 2008-12-23 | 2014-01-27 | Эбботт Лэборетриз | Антивирусные соединения |
| NZ705225A (en) | 2010-07-16 | 2016-11-25 | Abbvie Bahamas Ltd | Process for preparing antiviral compounds |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| US8841487B2 (en) | 2010-07-16 | 2014-09-23 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| WO2014042647A1 (en) * | 2012-09-14 | 2014-03-20 | Levina Elizabeth | Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| JP6156845B2 (ja) * | 2014-03-04 | 2017-07-05 | 株式会社島津製作所 | マトリックス支援レーザ脱離イオン化質量分析用マトリックス |
| SG11201609404SA (en) | 2014-05-29 | 2016-12-29 | Entasis Therapeutics Ltd | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| US10995097B2 (en) * | 2016-03-11 | 2021-05-04 | The Board Of Trustees Of The University Of Illinois | Small molecules active against gram-negative bacteria |
| US11274106B2 (en) | 2017-06-23 | 2022-03-15 | The Board Of Trustees Of The University Of Illinois | Topoisomerase inhibitors with antibacterial and anticancer activity |
| CN108101860B (zh) * | 2018-02-08 | 2021-11-23 | 苏州敬业医药化工有限公司 | 顺式-2,6-二甲基吗啉的制备方法 |
| CN115466212B (zh) * | 2022-10-26 | 2023-09-22 | 河南农业大学 | 一种2-三氟甲基喹啉类化合物及其合成方法和应用 |
| CN118878546B (zh) * | 2024-09-30 | 2025-01-03 | 苏州大学 | 一种螺环巴比妥酸衍生物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011860A (en) | 1986-04-11 | 1991-04-30 | Schering Corporation | Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases |
| DE19502178A1 (de) | 1994-01-27 | 1995-08-03 | Hoechst Ag | Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen |
| CZ20031083A3 (cs) | 2000-10-26 | 2004-03-17 | Pfizer Products Inc. | 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy |
| AU2003228701A1 (en) | 2002-04-25 | 2003-11-10 | Bristol-Myers Squibb Company | Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| WO2004033449A1 (en) | 2002-10-10 | 2004-04-22 | Pharmacia & Upjohn Company Llc | Antimicrobial 1-aryl dihydropyridone compounds |
-
2003
- 2003-10-02 US US10/677,551 patent/US7208490B2/en not_active Expired - Fee Related
- 2003-10-03 SI SI200331869T patent/SI1551849T1/sl unknown
- 2003-10-03 DE DE60333379T patent/DE60333379D1/de not_active Expired - Lifetime
- 2003-10-03 DK DK03799056.1T patent/DK1551849T3/da active
- 2003-10-03 AU AU2003264768A patent/AU2003264768A1/en not_active Abandoned
- 2003-10-03 JP JP2005500077A patent/JP4009652B2/ja not_active Expired - Fee Related
- 2003-10-03 PT PT03799056T patent/PT1551849E/pt unknown
- 2003-10-03 BR BR0315139-5A patent/BR0315139A/pt not_active IP Right Cessation
- 2003-10-03 MX MXPA05002701A patent/MXPA05002701A/es active IP Right Grant
- 2003-10-03 EP EP03799056A patent/EP1551849B1/en not_active Expired - Lifetime
- 2003-10-03 AT AT03799056T patent/ATE473985T1/de active
- 2003-10-03 CA CA2500824A patent/CA2500824C/en not_active Expired - Fee Related
- 2003-10-03 WO PCT/IB2003/004389 patent/WO2004031195A1/en not_active Ceased
- 2003-10-06 TW TW092127679A patent/TWI295671B/zh not_active IP Right Cessation
- 2003-10-07 AR ARP030103650A patent/AR041546A1/es not_active Application Discontinuation
-
2007
- 2007-03-07 US US11/715,213 patent/US7605157B2/en not_active Expired - Fee Related
-
2009
- 2009-08-28 US US12/549,407 patent/US20100022524A1/en not_active Abandoned
-
2010
- 2010-10-06 CY CY20101100894T patent/CY1110821T1/el unknown
- 2010-12-20 US US12/972,921 patent/US8420646B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CY1110821T1 (el) | 2015-06-10 |
| PT1551849E (pt) | 2010-09-27 |
| ATE473985T1 (de) | 2010-07-15 |
| CA2500824C (en) | 2011-03-22 |
| JP2006511595A (ja) | 2006-04-06 |
| US20110092494A1 (en) | 2011-04-21 |
| TWI295671B (en) | 2008-04-11 |
| US7605157B2 (en) | 2009-10-20 |
| TW200413394A (en) | 2004-08-01 |
| WO2004031195A1 (en) | 2004-04-15 |
| JP4009652B2 (ja) | 2007-11-21 |
| EP1551849B1 (en) | 2010-07-14 |
| SI1551849T1 (sl) | 2010-11-30 |
| US7208490B2 (en) | 2007-04-24 |
| DK1551849T3 (da) | 2010-10-25 |
| DE60333379D1 (de) | 2010-08-26 |
| US8420646B2 (en) | 2013-04-16 |
| US20070161630A1 (en) | 2007-07-12 |
| US20100022524A1 (en) | 2010-01-28 |
| CA2500824A1 (en) | 2004-04-15 |
| MXPA05002701A (es) | 2005-08-19 |
| US20040162279A1 (en) | 2004-08-19 |
| AU2003264768A1 (en) | 2004-04-23 |
| AR041546A1 (es) | 2005-05-18 |
| EP1551849A1 (en) | 2005-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0213063A (pt) | Antibióticos de ação dupla | |
| CY1110821T1 (el) | Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης | |
| BRPI0410630A (pt) | antagonista de nk1 | |
| DE69908819D1 (de) | Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten | |
| SE0102315D0 (sv) | Compounds | |
| BR0210028A (pt) | Agentes antibacterianos | |
| DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| CY1111246T1 (el) | Προληψη και θεραπεια επαγομενης απο φλεγμονη και/ή ανοσοδιαμεσολαβουμενης οστικης απωλειας | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| BR0210139A (pt) | Composições farmacêuticas | |
| EA200600971A1 (ru) | Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона | |
| BR0211972A (pt) | Composição oftálmica | |
| ES2171723T3 (es) | 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2. | |
| ES2243579T3 (es) | Derivados de pirazolopirideno. | |
| ES2186550A1 (es) | Nuevos derivados de oxazolidinonas como antibacterianos. | |
| BRPI0406824A (pt) | Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm | |
| NO20044549L (no) | Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer | |
| HRP20050517B1 (hr) | N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi | |
| MY146098A (en) | Oxazole derivatives of tetracyclines | |
| ECSP045405A (es) | Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa | |
| AU4568400A (en) | Sphingomyelinase inhibitor | |
| ITMI20021881A1 (it) | Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario. | |
| BR0211223A (pt) | Derivados de 4-aminociclohexanol substituìdos | |
| AU2003259159A1 (en) | N-aryl-2-oxazolidinones and their derivatives | |
| PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: PHARMACIA AND UPJOHN COMPANY LLC (US) |
|
| B25A | Requested transfer of rights approved |
Owner name: PAH PANDU LLC (US) |
|
| B25D | Requested change of name of applicant approved |
Owner name: ZOETIS PANDU LLC (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |